These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25081936)

  • 1. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients.
    Lichtner M; Cicconi P; Vita S; Cozzi-Lepri A; Galli M; Lo Caputo S; Saracino A; De Luca A; Moioli M; Maggiolo F; Marchetti G; Vullo V; d'Arminio Monforte A;
    J Infect Dis; 2015 Jan; 211(2):178-86. PubMed ID: 25081936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.
    Guech-Ongey M; Brenner H; Twardella D; Hahmann H; Rothenbacher D
    Int J Cardiol; 2006 Jul; 111(1):98-103. PubMed ID: 16229909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.
    Fowotade A; Okonko IO; Agbede OO; Suleiman ST
    Afr Health Sci; 2015 Mar; 15(1):1-9. PubMed ID: 25834524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive results of immunoglobulin G cytomegalovirus serologic testing and risk of severe non-AIDS-related complications in HIV-infected patients.
    Manfredi R
    J Infect Dis; 2015 Apr; 211(8):1356-7. PubMed ID: 25381369
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
    Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
    Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.
    Chakraborty A; Mahapatra T; Mahapatra S; Ansari S; Siddhanta S; Banerjee S; Banerjee D; Sarkar RN; Guha SK; Chakraborty N
    PLoS One; 2015; 10(2):e0117466. PubMed ID: 25679798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania.
    Brantsæter AB; Johannessen A; Holberg-Petersen M; Sandvik L; Naman E; Kivuyo SL; Rollag H; Bruun JN; Kvale D
    Int J Infect Dis; 2012 Dec; 16(12):e879-85. PubMed ID: 23031419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).
    Erice A; Tierney C; Hirsch M; Caliendo AM; Weinberg A; Kendall MA; Polsky B;
    Clin Infect Dis; 2003 Aug; 37(4):567-78. PubMed ID: 12905142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
    Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls.
    Ramendra R; Isnard S; Lin J; Fombuena B; Ouyang J; Mehraj V; Zhang Y; Finkelman M; Costiniuk C; Lebouché B; Chartrand-Lefebvre C; Durand M; Tremblay C; Ancuta P; Boivin G; Routy JP
    Clin Infect Dis; 2020 Sep; 71(6):1438-1446. PubMed ID: 31608409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of the plasma load of cytomegalovirus in patients infected with HIV--a survival analysis.
    Aramă V; Mihăilescu R; Rădulescu M; Aramă SŞ; Streinu-Cercel A; Youle M;
    J Med Virol; 2014 Nov; 86(11):1821-7. PubMed ID: 25087866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
    Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
    Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.
    Choi YL; Kim JA; Jang KT; Kim DS; Kim WS; Lee JH; Yang JM; Lee ES; Lee DY
    Br J Dermatol; 2006 Nov; 155(5):977-82. PubMed ID: 17034528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual factors associated with cytomegalovirus seropositivity in human immunodeficiency virus-infected men. The Seroco Study Group.
    Carré N; Robain M; Dussaix E; Salmon-Ceron D; Meyer L
    Sex Transm Dis; 1997 Nov; 24(10):582-6. PubMed ID: 9383847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort.
    Gkrania-Klotsas E; Langenberg C; Sharp SJ; Luben R; Khaw KT; Wareham NJ
    Clin Infect Dis; 2013 May; 56(10):1421-7. PubMed ID: 23442763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.